Abstract
There is no standard chemotherapy for advanced extramammary Paget's disease. Therefore, to establish a standard guideline for the treatment of extramammary Paget's disease, we have researched this disease in the Society of Extramammary Paget's Disease starting from 2006. At present, we treat it with docetaxel and study the effect. In this report, we mention the process by which we chose docetaxel, usage, side effects and the cost of treatment. However, docetaxel is not authorized as a treatment for extramammary Paget's disease and the effect is not clear. In several years, we will bring this research to a conclusion. [Skin Cancer (Japan)2008; 23: 347-354]
